CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 96 filers reported holding CARA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,698 | -40.6% | 28,987 | 0.0% | 0.00% | – |
| Q2 2023 | $82,033 | -49.2% | 28,987 | -11.9% | 0.00% | – |
| Q1 2023 | $161,637 | -37.3% | 32,920 | +37.1% | 0.00% | – |
| Q4 2022 | $257,964 | +42.5% | 24,019 | +24.4% | 0.00% | – |
| Q3 2022 | $181,000 | -10.8% | 19,308 | -12.8% | 0.00% | – |
| Q2 2022 | $203,000 | -32.1% | 22,153 | -9.9% | 0.00% | – |
| Q1 2022 | $299,000 | -9.9% | 24,594 | -9.8% | 0.00% | – |
| Q4 2021 | $332,000 | -15.9% | 27,277 | +6.7% | 0.00% | – |
| Q3 2021 | $395,000 | -78.1% | 25,553 | -79.8% | 0.00% | -100.0% |
| Q2 2021 | $1,803,000 | -53.7% | 126,376 | -29.6% | 0.00% | -50.0% |
| Q1 2021 | $3,896,000 | +734.3% | 179,434 | +482.0% | 0.00% | – |
| Q4 2020 | $467,000 | -35.9% | 30,830 | -46.1% | 0.00% | -100.0% |
| Q3 2020 | $728,000 | +100.0% | 57,241 | +168.7% | 0.00% | – |
| Q2 2020 | $364,000 | +101.1% | 21,299 | +55.6% | 0.00% | – |
| Q1 2020 | $181,000 | -21.6% | 13,689 | -5.3% | 0.00% | – |
| Q4 2019 | $231,000 | +13.2% | 14,448 | +29.1% | 0.00% | – |
| Q3 2019 | $204,000 | -5.6% | 11,190 | +10.8% | 0.00% | – |
| Q2 2019 | $216,000 | +6.4% | 10,101 | -3.5% | 0.00% | – |
| Q1 2019 | $203,000 | -94.9% | 10,467 | -96.6% | 0.00% | -100.0% |
| Q4 2018 | $3,953,000 | -54.1% | 304,177 | -15.4% | 0.00% | 0.0% |
| Q3 2018 | $8,608,000 | -44.5% | 359,430 | -55.6% | 0.00% | -25.0% |
| Q2 2018 | $15,513,000 | +663.4% | 810,119 | +393.4% | 0.00% | +300.0% |
| Q1 2018 | $2,032,000 | +123.8% | 164,203 | +120.7% | 0.00% | 0.0% |
| Q4 2017 | $908,000 | -55.4% | 74,405 | -50.0% | 0.00% | 0.0% |
| Q3 2017 | $2,038,000 | +27.8% | 148,953 | +43.5% | 0.00% | 0.0% |
| Q2 2017 | $1,595,000 | +389.3% | 103,783 | +483.9% | 0.00% | – |
| Q1 2017 | $326,000 | +44.2% | 17,775 | -27.4% | 0.00% | – |
| Q4 2016 | $226,000 | -73.2% | 24,499 | -75.8% | 0.00% | -100.0% |
| Q3 2016 | $843,000 | +1305.0% | 101,185 | +699.1% | 0.00% | – |
| Q2 2016 | $60,000 | -76.7% | 12,662 | -69.6% | 0.00% | – |
| Q1 2016 | $258,000 | +106.4% | 41,625 | +456.7% | 0.00% | – |
| Q4 2015 | $125,000 | -89.3% | 7,477 | -90.9% | 0.00% | -100.0% |
| Q3 2015 | $1,168,000 | +2333.3% | 81,820 | +1932.8% | 0.00% | – |
| Q2 2015 | $48,000 | -94.4% | 4,025 | -95.3% | 0.00% | -100.0% |
| Q1 2015 | $858,000 | +627.1% | 85,424 | +614.2% | 0.00% | – |
| Q4 2014 | $118,000 | – | 11,960 | +24816.7% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 48 | -98.2% | 0.00% | – |
| Q2 2014 | $45,000 | +87.5% | 2,670 | +100.0% | 0.00% | – |
| Q1 2014 | $24,000 | – | 1,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |